Literature DB >> 31218878

Neuroinvasive West Nile Virus Disease in an Elderly Patient with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Therapy: A Case Report

Barış Arslan1, Hasan Murat Gündüz2, Nurdan Ünlü1, Gökhan Çavuş3, Dilek Menemenlioğlu4.   

Abstract

Background: West Nile virus is an arthropod-borne virus (arbovirus) and emerging cause of significant illness in European and Mediterranean countries. West Nile virus infection can cause severe and potentially fatal neurological illnesses, including encephalitis, meningitis, and acute flaccid paralysis. Additionally, immunosuppression, alcohol abuse, old age, and diabetes mellitus are common factors associated with West Nile neuroinvasive disease. Case Report: In August 2018, a 60-year-old male patient with a history of diffuse large B-cell lymphoma initially presented with symptoms including abdominal pain and distention, nausea, and vomiting. Three days after open abdominal surgery due to adhesive small bowel obstruction, he developed fever, prominent tremors, and rapidly progressing flaccid paralysis. The identification of West Nile virus RNA in the serum sample led to the diagnosis of West Nile neuroinvasive disease.
Conclusion: Clinicians should evaluate patients with acute flaccid paralysis for the evidence of West Nile neuroinvasive disease. It is particularly important for healthcare providers to consider West Nile neuroinvasive disease in the differential diagnosis of aseptic meningitis, encephalitis, and acute paralysis cases, especially in endemic areas.

Entities:  

Keywords:  West Nile virus; Lymhoma; Turkey

Year:  2019        PMID: 31218878      PMCID: PMC6711251          DOI: 10.4274/balkanmedj.galenos.2019.2018.12.74

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  7 in total

1.  Seronegative West Nile Virus Infection in a Patient Treated with Rituximab for Rheumatoid Arthritis.

Authors:  Chris Goates; Sanefumi Tsuha; Selene Working; Jessica Carey; Emily S Spivak
Journal:  Am J Med       Date:  2017-02-03       Impact factor: 4.965

2.  Maculopapular rash and tremor are associated with West Nile fever and neurological syndromes.

Authors:  Peter A G Tilley; Julie D Fox; Gayatri C Jayaraman; Jutta K Preiksaitis
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-05       Impact factor: 10.154

3.  Pathogenesis of West Nile virus lineage 1 and 2 in experimentally infected large falcons.

Authors:  Ute Ziegler; Joke Angenvoort; Dominik Fischer; Christine Fast; Martin Eiden; Ariel V Rodriguez; Sandra Revilla-Fernández; Norbert Nowotny; Jorge García de la Fuente; Michael Lierz; Martin H Groschup
Journal:  Vet Microbiol       Date:  2012-08-03       Impact factor: 3.293

4.  Neurologic manifestations and outcome of West Nile virus infection.

Authors:  James J Sejvar; Maryam B Haddad; Bruce C Tierney; Grant L Campbell; Anthony A Marfin; Jay A Van Gerpen; Aaron Fleischauer; A Arturo Leis; Dobrivoje S Stokic; Lyle R Petersen
Journal:  JAMA       Date:  2003-07-23       Impact factor: 56.272

Review 5.  Rituximab-related viral infections in lymphoma patients.

Authors:  Sercan Aksoy; Hakan Harputluoglu; Saadettin Kilickap; Didem Sener Dede; Omer Dizdar; Kadri Altundag; Ibrahim Barista
Journal:  Leuk Lymphoma       Date:  2007-07

6.  West Nile virus-associated flaccid paralysis.

Authors:  James J Sejvar; Amy V Bode; Anthony A Marfin; Grant L Campbell; David Ewing; Michael Mazowiecki; Pierre V Pavot; Joseph Schmitt; John Pape; Brad J Biggerstaff; Lyle R Petersen
Journal:  Emerg Infect Dis       Date:  2005-07       Impact factor: 6.883

Review 7.  A review of the epidemiological and clinical aspects of West Nile virus.

Authors:  Timothy J Gray; Cameron E Webb
Journal:  Int J Gen Med       Date:  2014-04-11
  7 in total
  1 in total

1.  Recruiting the innate immune system with GM-CSF to fight viral diseases, including West Nile Virus encephalitis and COVID-19.

Authors:  Huntington Potter; Timothy D Boyd; Penny Clarke; Victoria S Pelak; Kenneth L Tyler
Journal:  F1000Res       Date:  2020-05-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.